The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity
Abstract
Lymphoid cells from many normal mice of a variety of inbred strains were found to have reactivity, in a 51 Cr release cytotoxicity assay, against several syngeneic and allogeneic tumors. Very high reactivity was seen with effector cells from athymic nude mice, which was consistent with other evidence that the reactivity was not T‐cell dependent. Target cells susceptible to lysis included tumors induced by oncogenic type‐C viruses but also tumors induced by other means and expressing endogenous type‐C viruses. The levels of natural reactivity were influenced by age, with highest cytotoxicity produced by cells from 5‐ to 8‐week‐old mice. Lymph‐node cells, spleen cells, peritoneal exudate cells and peripheral blood lymphocytes all had cytotoxic reactivity. The specificity of the reactions was analyzed in detail by an inhibition assay. Evidence was obtained for natural reactivity against several different antigens, each apparently associated with expression of murine endogenous type‐C viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kiessling, R., Klein, E., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050208 · Cited by 1,824
Kiessling, R., Klein, E., Pross, H., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050209 · Cited by 1,143
Herberman, R. B., Nunn, M. E., Holden, H. T., & Lavrin, D. H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910160205 · Cited by 885
Self-citationKiessling, R., Petranyi, G., Klein, G., & Wigzell, H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910150608 · Cited by 228
Rosenberg, E. B., McCoy, J. L., Green, S. S., Donnelly, F. C., Siwarski, D. F., Levine, P. H., & Herberman, R. B. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/52.2.345 · Cited by 186
Self-citationLymphocyte cytotoxicity reactions to leukemia‐associated antigens in identical twins
ROSENBERG, E. B., Herberman, R. B., Levine, P. H., Halterman, R. H., McCov, J. L., & Wunderlich, J. R. (1972) · International Journal of Cancer · doi:10.1002/ijc.2910090323 · Cited by 146
Self-citationSendo, F., Aoki, T., Boyse, E. A., & Buafo, C. K. (1975) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/55.3.603 · Cited by 145
Oldstone, M. B. A., Aoki, T., & Dixon, F. J. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.1.134 · Cited by 124
Aaronson, S. A., & Stephenson, J. R. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.5.1957 · Cited by 75
Research works printed but not linked: 24
- Aoki T., 1966, Occurrence of natural antibody to the G (Gross) leukemia antigen in mice, Cancer Res., 26, 1415
- Blair P. B., 1974, Immunologic evidence for horizontal transmission of MTV, J. Immunol., 113, 1446, 10.4049/jimmunol.113.5.1446 · doi:10.4049/jimmunol.113.5.1446
- Blair P. B., 1974, In vitro detection of immune response to MTV‐induced mammary tumors: Activity of spleen cells from both MTV‐free and MTV‐infected mice, J. Immunol., 112, 693, 10.4049/jimmunol.112.2.693 · doi:10.4049/jimmunol.112.2.693
- Canty T. G., 1970, Quantitative in vitro assay of cytotoxic cellular immunity, J. nat. Cancer Inst., 45, 761
- Greenberg A. H., 1974, Spontaneously arising cytotoxicity to the P‐815‐Y mastocytoma in NZB mice, Clin. exp. Immunol., 16, 99
- Hanna M. G., 1972, Autogenous immunity to endogenous RNA tumor virus antigens in mice with low natural incidence of lymphoma, Cancer Res., 32, 2226
- 10.1084/jem.136.1.94 · doi:10.1084/jem.136.1.94
- 10.1093/jnci/53.4.1103 · doi:10.1093/jnci/53.4.1103
- 10.1093/jnci/51.5.1509 · doi:10.1093/jnci/51.5.1509
- Herberman R. B., 1974, Progress in immunology, II, 285
- 10.1084/jem.138.1.194 · doi:10.1084/jem.138.1.194
- Kaplan M. H., 1967, Cross‐reacting antigens and neoantigens, 48
- 10.1093/jnci/51.5.1497 · doi:10.1093/jnci/51.5.1497
- McCoy J. L., 1973, 51Chromium‐release assay for cell‐mediated cytotoxicity of human leukemia and lymphoid tissue‐culture cells, Nat. Cancer Inst. Monogr., 37, 59
- 10.1126/science.185.4154.869 · doi:10.1126/science.185.4154.869
- Nunn M., 1973, Natural cytotoxic reactivity of rat lymphocytes against syngeneic Gross leukemia, Proc. Amer. Ass. Cancer Res., 14, 87
- Oldham R. K., 1973, Evaluation of a cell‐mediated cytotoxicity assay utilizing 125Iododeoxyuridine‐labelled tissue‐culture target cells, Nat. Cancer Inst., Monogr., 37, 49
- Oldham R. K. Weiner R. S. Mathe G. Breard J. Simmler M. C. Carde P. andHerberman R. B. Cell‐mediated immune responsiveness of patients with acute lymphocytic leukemia in remission.J. nat. Cancer Inst. in press (1975). · doi:10.1002/ijc.2910170308
- Ortiz de Landazuri M., 1972, Immune response to Gross virus‐induced lymphoma. III. Characteristics of the cellular immune response, J. nat. Cancer Inst., 49, 147
- 10.1084/jem.138.3.593 · doi:10.1084/jem.138.3.593
- Springer G. F., 1967, Cross‐reacting antigens and neoantigens, 29
- Stanton M. F., 1968, Some biologic, immunogenic and morphologic effects in mice after infection with a murine sarcoma virus. II. Morphologic studies, J. nat. Cancer Inst., 40, 1113
- 10.1038/253142a0 · doi:10.1038/253142a0
- Takasugi M., 1974, Studies on specificity of cell‐mediated immunity to human tumors, J. nat. Cancer Inst., 53, 1527
Cited by
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
Zinkernagel, R. M., & Doherty, P. C. (1979) · Advances in Immunology · doi:10.1016/s0065-2776(08)60262-x · Cited by 1,933
Natural Killer Cells: Their Roles in Defenses Against Disease
Herberman, R. B., & Ortaldo, J. R. (1981) · Science · doi:10.1126/science.7025208 · Cited by 1,336
Self-citationNK cells for cancer immunotherapy
Shimasaki, N., Jain, A., & Campana, D. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0052-1 · Cited by 1,222
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Abel, A. M., Yang, C., Thakar, M. S., & Malarkannan, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01869 · Cited by 1,150
Natural Cell-Mediated Immunity
(1978) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60936-7 · Cited by 1,053
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Interleukin-2 augments natural killer cell activity
Henney, C. S., Kuribayashi, K., Kern, D. E., & Gillis, S. (1981) · Nature · doi:10.1038/291335a0 · Cited by 913
Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15
Lucas, M., Schachterle, W., Oberle, K., Aichele, P., & Diefenbach, A. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.006 · Cited by 887
Herberman, R. B., Nunn, M. E., Holden, H. T., & Lavrin, D. H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910160205 · Cited by 885
Self-citationRECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Targeting natural killer cells and natural killer T cells in cancer
Vivier, E., Ugolini, S., Blaise, D., Chabannon, C., & Brossay, L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3174 · Cited by 850
Enhanced NK cell activity in mice injected with interferon and interferon inducers
GIDLUND, M., ÖRN, A., WIGZELL, H., SENIK, A., & GRESSER, I. (1978) · Nature · doi:10.1038/273759a0 · Cited by 734
Trinchieri, G., & Santoli, D. (1978) · The Journal of experimental medicine · doi:10.1084/jem.147.5.1314 · Cited by 733
NK cell-based cancer immunotherapy: from basic biology to clinical development
Liu, S., Galat, V., Galat4, Y., Lee, Y. K. A., Wainwright, D., & Wu, J. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01014-w · Cited by 689
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
NK cell-based immunotherapy for malignant diseases
Cheng, M., Chen, Y., Xiao, W., Sun, R., & Tian, Z. (2013) · Cellular & Molecular Immunology · doi:10.1038/cmi.2013.10 · Cited by 631
Marcus, A., Mao, A. J., Lensink-Vasan, M., Wang, L., Vance, R. E., & Raulet, D. H. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.016 · Cited by 611
Self-tolerance of natural killer cells
Raulet, D. H., & Vance, R. E. (2006) · Nature Reviews Immunology · doi:10.1038/nri1863 · Cited by 608
The Dynamic Life of Natural Killer Cells
Yokoyama, W. M., Kim, S., & French, A. R. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104711 · Cited by 577
Natural Killer Cells: Characteristics and Regulation of Activity
Herberman, R. B., Djeu, J. Y., Kay, H. D., Ortaldo, J. R., Riccardi, C., Bonnard, G. D., Holden, H. T., Fagnani, R., Santoni, A., & Puccetti, P. (1979) · Immunological Reviews · doi:10.1111/j.1600-065x.1979.tb00267.x · Cited by 575
Self-citationp46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., & Moretta, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1129 · Cited by 554
The Virology and Immunobiology of Lymphocytic Choriomeningitis Virus Infection
Buchmeier, M. J., Welsh, R. M., Dutko, F. J., & Oldstone, M. B. A. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60197-2 · Cited by 545
Prospects for the use of NK cells in immunotherapy of human cancer
Ljunggren, H.-G., & Malmberg, K.-J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2073 · Cited by 543
Tumor Immunology and Tumor Evolution: Intertwined Histories
Galon, J., & Bruni, D. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.018 · Cited by 540
A glycolipid on the surface of mouse natural killer cells
Kasai, M., Iwamod, M., Nagai, Y., Okumura, K., & Tada, T. (1980) · European Journal of Immunology · doi:10.1002/eji.1830100304 · Cited by 535
Regulation of the Natural Killer Cell Receptor Repertoire
Raulet, D. H., Vance, R. E., & McMahon, C. W. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.291 · Cited by 521
Beverley, P. C. L., & Callard, R. E. (1981) · European Journal of Immunology · doi:10.1002/eji.1830110412 · Cited by 494
Ganal, S. C., Sanos, S. L., Kallfass, C., Oberle, K., Johner, C., Kirschning, C., Lienenklaus, S., Weiss, S., Staeheli, P., Aichele, P., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.020 · Cited by 484
Kopp, H.-G., Placke, T., & Salih, H. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2123 · Cited by 469
Kiessling, R., Hochman, P. S., Haller, O., Shearer, G. M., Wigzell, H., & Cudkowicz, G. (1977) · European Journal of Immunology · doi:10.1002/eji.1830070915 · Cited by 460
Uterine NK cells: active regulators at the maternal-fetal interface
Moffett, A., & Colucci, F. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68107 · Cited by 453
NATURAL KILLER CELL DEVELOPMENTAL PATHWAYS: A Question of Balance
Di Santo, J. P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090700 · Cited by 448
The Natural Cytotoxicity Receptors in Health and Disease
Barrow, A. D., Martin, C. J., & Colonna, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00909 · Cited by 370
Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
Moretta, A., Biassoni, R., Bottino, C., Mingari, M. C., & Moretta, L. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01596-6 · Cited by 354
Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C., & Moretta, L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00943.x · Cited by 350
An Analysis of the Murine NK Cell as to Structure, Function and Biological Relevance
Kiessling, R., & Wigzell, H. (1979) · Immunological Reviews · doi:10.1111/j.1600-065x.1979.tb00270.x · Cited by 350
Human Cell Hybrids: Analysis of Transformation and Tumorigenicity
Stanbridge, E. J., Der, C. J., Doersen, C.-J., Nishimi, R. Y., Peehl, D. M., Weissman, B. E., & Wilkinson, J. E. (1982) · Science · doi:10.1126/science.7053574 · Cited by 340
Bi, J., & Tian, Z. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00760 · Cited by 325
NK Cells, MHC Class I Molecules and the Missing Self
Kärre, K. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2002.01053.x · Cited by 325
Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma
Doubrovina, E. S., Doubrovin, M. M., Vider, E., Sisson, R. B., O’Reilly, R. J., Dupont, B., & Vyas, Y. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6891 · Cited by 324
NK cell-based immunotherapy for cancer
Fang, F., Xiao, W., & Tian, Z. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.07.009 · Cited by 306
Natural killer cell recognition of missing self
Kärre, K. (2008) · Nature Immunology · doi:10.1038/ni0508-477 · Cited by 296
Welsh, J. R. (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.148.1.163 · Cited by 293
Joncker, N. T., Fernandez, N. C., Treiner, E., Vivier, E., & Raulet, D. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803900 · Cited by 291
Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease
Nielsen, C. M., White, M. J., Goodier, M. R., & Riley, E. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00422 · Cited by 282
Natural cytotoxicity receptors and their ligands
Kruse, P. H., Matta, J., Ugolini, S., & Vivier, E. (2014) · Immunology & Cell Biology · doi:10.1038/icb.2013.98 · Cited by 273
Developmental and Functional Control of Natural Killer Cells by Cytokines
Wu, Y., Tian, Z., & Wei, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00930 · Cited by 269
Rodewald, H.-R., Moingeon, P., Lucich, J. L., Dosiou, C., Lopez, P., & Reinherz, E. L. (1992) · Cell · doi:10.1016/0092-8674(92)90125-v · Cited by 255
IL-15 signaling in NK cell cancer immunotherapy
Rautela, J., & Huntington, N. D. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.10.004 · Cited by 125
Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease
Martínez-Chantar, M. L., Delgado, T. C., & Beraza, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640869 · Cited by 67
Veluchamy, J. P., Lopez-Lastra, S., Spanholtz, J., Bohme, F., Kok, N., Heideman, D. A. M., Verheul, H. M. W., Di Santo, J. P., de Gruijl, T. D., & van der Vliet, H. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00087 · Cited by 54
Metadata
- Authors
- Herberman, R. B., Nunn, M. E., & Lavrin, D. H.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1975-08-15
- Volume
- 16
- Issue
- 2
- Pages
- 216-229
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2147787458
- Cited by
- 1,355
- References
- 9
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.